Risk Behaviour and Time as Covariates for Efficacy of the HIV Vaccine Regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: A Post-Hoc Analysis of the Thai Phase 3 Efficacy Trial RV 144. Lancet Inf Dis, 12, 531-537. presented at the 07/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22652344. (2012).
Statistical Interpretation of the RV144 HIV Vaccine Efficacy Trial in Thailand: a Case Study for Statistical Issues in Efficacy Trials. J Infect Dis, 203, 969-975. presented at the 04/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21402548. (2011).
Bayesian Prediction of Enrollment in Clinical Trials. presented at the 2006.. (2006).